- n an oral antagonist against the action of opiates
- Comparing patients who received the naltrexone shots to those who received placebos, she found a reduction in the number of days the subjects drank and on those days they .
- But naltrexone is controversial because for some, it doesn't do anything to reduce the craving for alcohol until those addicts actually take a drink, whereupon it helps them resist .
- For study participants who fit that description, naltrexone was no better than a placebo in reducing alcohol consumption.
News & Articles
- Successful treatment of triple negative breast cancer by modulation of the OGF-OGFr axis
Human triple-negative breast cancer can be treated by modulation of the opioid growth factor (OGF) - OGFr pathway. OGF suppresses cell growth by 20 percent within 24 hours in a receptor-mediated manner. Blockade of OGFr using low dosages of the opioid antagonist naltrexone causes a compensatory increase in OGF and results in 35 percent reductions in cell number within 72 hours. These data ...
Aug. 10, 2013 - Science Daily
- Treatment for PTSD and risk of drinking among individuals with alcohol dependence
( The JAMA Network Journals ) In a trial that included patients with alcohol dependence and posttraumatic stress disorder (PTSD), treatment with the drug naltrexone resulted in a decrease in the percentage of days drinking while use of the PTSD treatment, prolonged exposure therapy, was not associated with increased drinking or alcohol craving, according to a study in the Aug. 7 issue of JAMA, a ...
Aug. 6, 2013 - EurekAlert!
- Nick Xenophon in ABC Online
There is a double standard,Mr Xenophon said. "Governments fund Naltrexone for people with an opiate dependency...... but state governments and federal governments, indirectly, are getting billions of dollars a year nationally from poker...